Publications by authors named "V A Glazunova"

The phase 3 SELENE study evaluated ibrutinib + chemoimmunotherapy (CIT; bendamustine and rituximab [BR]; or rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) for patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL). Adult patients who had received ≥1 prior line of CIT were randomized 1:1 to oral ibrutinib (560 mg) or placebo daily, plus 6 cycles of BR/R-CHOP. The primary end point was investigator-assessed progression-free survival (PFS).

View Article and Find Full Text PDF

Mixed simplified structures containing the paclitaxel and eleutherobin pharmacophore moieties were analyzed using molecular docking techniques and synthesized based on adamantane and 8-oxabicyclo[3.2.1]octane scaffolds.

View Article and Find Full Text PDF

Objective: To synthesize a novel chemotype based on the naphthoquinone scaffold with retained cytotoxicity and provisionally low intracellular oxidation potential.

Background: Derivatives of naphthoquinone, although potent anticancer agents, can exert heart toxicity due to generation of free oxygen species.

Methods: In this study, we modified the scaffold by replacing one carbonyl group with the oxime moiety.

View Article and Find Full Text PDF

It was shown that Ag(or AgO)-ZrO-YO formation occurs due to the complex process of decomposition and structure transformation of oxide materials and Ag-complexes. Differences in the decomposition temperatures of Ag-complexes, in particular, and their melting temperatures, and the transformation of ZrO-YO NPs morphology leads to the creation of composite structure of two types: an Ag-NPs/zirconia matrix and zirconia core/Ag-shell. It was shown that for these composites the temperature is an effective approach for controlling the NPs sizes for both components (Ag clusters and zirconia NPs), the defectiveness of the complex oxide and their optical properties, in particular the photosensitive to visible irradiation range.

View Article and Find Full Text PDF

A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11-14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11-14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD(+)/NADH ratio through tNOX inhibition, suppression of a NAD(+)-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis.

View Article and Find Full Text PDF